One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique

Nat Commun. 2025 Aug 7;16(1):7295. doi: 10.1038/s41467-025-62454-x.

Abstract

Human papillomavirus (HPV) is responsible for nearly all cases of cervical cancer. Affordable point-of-care DNA testing is needed for cervical cancer screening in low- and middle-income countries, where most cervical cancer cases occur. HPV DNA testing typically requires complex lab infrastructure and trained personnel. In this work, we develop a loop-mediated isothermal amplification (LAMP)-based HPV DNA test, which targets three of the most oncogenic HPV types (HPV16, HPV18, HPV45) and a cellular control and achieves analytical sensitivity comparable to gold standard methods. Our extraction-free sample preparation strategy permits adding sample lysate directly to the LAMP reaction. We utilize a low-cost benchtop heater/fluorimeter, delivering results in less than one hour. We analytically evaluate our assay with clinical samples in Houston, Texas (n = 38) and Maputo, Mozambique (n = 191). Results show 100% and 93% concordance, respectively, with a reference test widely used in low-resource settings. This sensitive and specific four-step assay can potentially expand cervical cancer screening in resource-limited settings.

MeSH terms

  • DNA, Viral* / genetics
  • Early Detection of Cancer / methods
  • Female
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 18 / genetics
  • Humans
  • Molecular Diagnostic Techniques* / methods
  • Mozambique
  • Nucleic Acid Amplification Techniques* / methods
  • Papillomaviridae* / genetics
  • Papillomaviridae* / isolation & purification
  • Papillomavirus Infections* / diagnosis
  • Papillomavirus Infections* / virology
  • Point-of-Care Testing*
  • Sensitivity and Specificity
  • Texas
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / virology

Substances

  • DNA, Viral

Supplementary concepts

  • LAMP assay